USPTO Examiner IGBOKO CHIMA U - Art Unit 3771

Recent Applications

Detailed information about the 100 most recent patent applications.

Application NumberTitleFiling DateDisposal DateDispositionTime (months)Office ActionsRestrictionsInterviewAppeal
19244937EMULSIFICATION DEVICES AND METHODS FOR CRYSTALLINE LENS REMOVALJune 2025September 2025Allow300YesNo
19048877DEVICE AND METHOD FOR GENERATING A CHANNEL IN AN EYE TISSUE LAYER FOR TREATMENT OF OCULAR DISORDERSFebruary 2025October 2025Allow820NoNo
18393411DIRECTIONAL STENT FOR ACCESSING EXTRAVASCULAR SPACESDecember 2023January 2026Allow2500YesNo
18288336PUNCHING-TYPE IRIDOTOMY INSTRUMENTOctober 2023October 2025Allow2410NoNo
18486110RETRACTABLE CAP ACTUATION FOR AN INTRAOCULAR LENS CARTRIDGEOctober 2023September 2025Allow2300YesNo
18355857VIBRATION INDUCED MEMBRANE RUPTUREJuly 2023November 2023Allow410YesNo
18209061SURGICAL INSTRUMENTS WITH ARTICULATING SHAFTSJune 2023February 2026Allow3210YesNo
18320484HAPTIC OPTIC MANAGEMENT SYSTEM UTILIZING EDGE ROLLERSMay 2023February 2026Allow3310YesNo
18113577METHODS AND SYSTEMS FOR ALIGNING A COMMISSURE OF A PROSTHETIC HEART VALVE WITH A COMMISSURE OF A NATIVE VALVEFebruary 2023October 2023Allow801NoNo
18112924ERGONOMIC FORCEPS TOOLFebruary 2023December 2025Allow3400NoNo
18098291DEVICE AND METHOD FOR CREATING A CHANNEL IN SOFT TISSUEJanuary 2023June 2023Allow500YesNo
18093564DEVICES AND METHODS FOR CONTROLLED DELIVERY OF A STENTJanuary 2023October 2025Allow3410YesNo
18084041TISSUE EXPANDERS AND METHODS OF USE THEREOFDecember 2022June 2025Abandon3010NoNo
18079240AORTIC BIOPROSTHESIS AND SYSTEMS FOR DELIVERY THEREOFDecember 2022October 2025Allow3420YesNo
18001387INJECTOR ASSEMBLY FOR INSERTING AN INTRAOCULAR LENS AND INJECTORDecember 2022July 2023Allow810NoNo
18001377INJECTOR ASSEMBLY FOR INSERTING AN INTRAOCULAR LENS AND INJECTORDecember 2022June 2023Allow600YesNo
18077897IMPLANT HAVING FILAMENT LIMBS OF AN ADJUSTABLE LOOP DISPOSED IN A SHUTTLE SUTUREDecember 2022September 2025Allow3310YesNo
18058045FOLDING DEVICE FOR INTRAOCULAR LENS INJECTORNovember 2022October 2025Allow3501YesNo
17992445THROMBECTOMY APPARATUSESNovember 2022August 2025Allow3210YesNo
18055671HAPTIC OPTIC MANAGEMENT SYSTEM UTILIZING ROTATING CAMSNovember 2022February 2026Allow3911YesNo
17977079DEVICE AND METHOD FOR TREATING VASCULAR OCCLUSIONOctober 2022June 2024Abandon1920NoNo
17968656THROMBECTOMY SYSTEMS AND DEVICES AND METHODS OF USING THE SAMEOctober 2022May 2025Abandon3110NoNo
17819990HAPTIC MANAGEMENT FOR SURGICAL IMPLANTSAugust 2022February 2026Allow4210YesNo
17888454ATHERECTOMY SYSTEM WITH GUIDEWIRE DETECTIONAugust 2022March 2025Allow3101YesNo
17886824INTRAVASCULAR CATHETER HAVING AN EXPANDABLE INCISING PORTION AND EMBOLIC PROTECTION DEVICEAugust 2022August 2025Allow3710YesNo
17886605INTRAVASCULAR CATHETER HAVING AN EXPANDABLE INCISING PORTION AND EMBOLIC PROTECTION DEVICEAugust 2022August 2025Allow3620YesYes
17883295METHODS AND SYSTEMS FOR TREATMENT OF ACUTE ISCHEMIC STROKEAugust 2022June 2024Allow2230YesNo
17818055INTRAOCULAR LENS INJECTORAugust 2022February 2025Allow3110YesNo
17817728IOL INJECTOR WITH AUTOMATIC DRIVER OR ASSISTED MANUAL DRIVE FORCEAugust 2022November 2025Allow3911YesNo
17875142INJECTOR ASSEMBLY FOR INSERTING AN INTRAOCULAR LENSJuly 2022December 2024Allow2821YesNo
17868076TISSUE EXPANSION DEVICES, SYSTEMS AND METHODSJuly 2022August 2024Allow2500YesNo
17856435INTRAVASCULAR CATHETER HAVING AN EXPANDABLE INCISING PORTIONJuly 2022June 2025Allow3620YesNo
17833969SCALP ROLLER AND METHOD FOR TATTOOINGJune 2022July 2025Allow3720YesNo
17828749DEVICE AND METHOD FOR CREATING A CHANNEL IN SOFT TISSUEMay 2022December 2022Allow710YesNo
17826280TRANS-VAGINAL CUFF ANCHOR AND METHOD OF DEPLOYING SAMEMay 2022September 2024Allow2700YesNo
17825074CLOT RETRIEVER CLEANING FOR REINSERTIONMay 2022September 2024Allow2800YesNo
17825537METHODS, COMPOSITIONS, AND DEVICES FOR THE OCCLUSION OF CAVITIES AND PASSAGEWAYSMay 2022April 2023Allow1110YesNo
17748523METHODS AND SYSTEMS FOR TREATMENT OF ACUTE ISCHEMIC STROKEMay 2022August 2022Allow300NoNo
17745708DEVICES AND METHODS FOR CREATING A CAPSULORHEXISMay 2022December 2025Allow4330YesNo
17729699LEFT ATRIAL APPENDAGE OCCLUDER DEVICEApril 2022February 2023Allow1020YesNo
17728214INTRAVASCULAR CATHETER HAVING AN EXPANDABLE INCISING PORTION AND ABRASIVE SURFACESApril 2022May 2024Allow2500NoNo
17660223OPHTHALMIC SURGICAL TOOLApril 2022June 2025Allow3820NoNo
17716068ENDOPROSTHESIS DELIVERY SYSTEMS WITH DEPLOYMENT AIDSApril 2022September 2025Allow4220YesNo
17704258DEVICE AND METHOD FOR TREATING VASCULAR OCCLUSIONMarch 2022May 2023Abandon1320YesNo
17703200RECIPROCATING SERRATED BLADE FOR PRECISION DISSECTIONMarch 2022January 2026Allow4620YesNo
17700067PROSTHETIC SUTURING DEVICE AND METHODS THEREOFMarch 2022November 2024Allow3210NoNo
17690774STENT ALIGNMENT DURING TREATMENT OF A BIFURCATIONMarch 2022April 2024Allow2610NoNo
17678139VASCULAR STENT DEVICES AND METHODSFebruary 2022July 2025Allow4040YesNo
17669463SURGICAL SUTURING INSTRUMENTSFebruary 2022April 2024Allow2600YesNo
17590081OPHTHALMIC MEDICAL INSTRUMENT WITH ILLUMINATED SNAREFebruary 2022June 2022Allow510NoNo
17645372HYBRID POWER DELIVERY FOR SURGICAL IMPLANTSDecember 2021February 2025Allow3711YesNo
17595311APPARATUS, SYSTEM AND METHOD OF PROVIDING A SURGICAL HANDPIECE HAVING AN EMULSIFYING TIP CAPABLE OF TRANSVERSE AND LONGITUDINAL MOTIONNovember 2021July 2025Allow4410NoNo
17521571CARDIAC VALVE REPAIR DEVICES CONFIGURED FOR PERCUTANEOUS DELIVERYNovember 2021November 2024Allow3611YesNo
17519533THROMBECTOMY APPARATUSESNovember 2021July 2022Allow811YesNo
17452600FLUID DRIVEN VITRECTOMY PROBEOctober 2021April 2024Allow2910NoNo
17499245FULL EVERSION ANASTOMOSIS JUNCTURE FORMATION AND SUTURINGOctober 2021October 2025Allow4801YesNo
17476600MULTI-DIAPHRAGM VITRECTOMY PROBESeptember 2021March 2025Allow4210YesNo
17476215DELIVERY AND RETRIEVAL DEVICES AND METHODS FOR SIDE-DELIVERABLE TRANSCATHETER PROSTHETIC VALVESSeptember 2021March 2022Allow601YesNo
17435762INTRAOCULAR LENS INJECTORSeptember 2021August 2025Allow4820YesNo
17412336ANCHOR DELIVERY SYSTEMAugust 2021July 2025Allow4640YesNo
17407809PERCUTANEOUS CATHETER DIRECTED INTRAVASCULAR OCCLUSION DEVICESAugust 2021March 2025Allow4320YesNo
17445153MEDICAL SYSTEMS, DEVICES, AND RELATED METHODSAugust 2021April 2025Allow4441YesNo
17428703IMPLANTATION DEVICEAugust 2021April 2025Allow4520YesNo
17390769ANNULOPLASTY RING DELIVERY CATHETERSJuly 2021March 2025Allow4310YesNo
17443789SUTURE DELIVERY SYSTEMJuly 2021October 2024Abandon3810NoNo
17384930Soft Suture AnchorJuly 2021April 2025Abandon4520YesNo
17375279MEDICAL TOOLS FOR CORNEAL TISSUE DELIVERYJuly 2021April 2024Allow3410YesNo
17364121MEDICAL DEVICE AND TREATMENT METHODJune 2021June 2025Allow4740NoNo
17360225MEDICAL DEVICE AND TREATMENT METHODJune 2021September 2024Allow3920YesNo
17303322RETRIEVAL SYSTEMS AND METHODS FOR USE THEREOFMay 2021January 2025Allow4430YesNo
17292970CAPSULOTOMY DEVICE AND METHODMay 2021March 2025Allow4621YesNo
17302693SURGICAL GUIDEMay 2021July 2025Allow5030YesNo
17241456KNOTLESS SUTURE ANCHOR SYSTEM WITH SUTURE MANAGEMENT STRUCTUREApril 2021June 2025Abandon4941YesNo
17221473INTRAVASCULAR CATHETER HAVING AN EXPANDABLE INCISING PORTIONApril 2021September 2024Allow4220YesNo
17221539INTRAVASCULAR CATHETER HAVING AN EXPANDABLE INCISING PORTIONApril 2021February 2025Allow4730YesNo
17193946DELIVERY AND RETRIEVAL DEVICES AND METHODS FOR SIDE-DELIVERABLE TRANSCATHETER PROSTHETIC VALVESMarch 2021August 2021Allow500YesNo
17181517Tethers For Prosthetic Mitral ValveFebruary 2021May 2024Abandon3910NoNo
17181537PHOTON-ACTIVATABLE GEL COATED INTRACRANIAL STENT AND EMBOLIC COILFebruary 2021December 2024Allow4611YesNo
17167468PATIENT INTRODUCER ALIGNMENTFebruary 2021May 2025Allow5121NoNo
17167491ALIGNMENT FEATURES FOR ULTRASONIC SURGICAL INSTRUMENTFebruary 2021September 2024Abandon4410NoNo
17156291MULTI-LUMEN CATHETER DEVICES, SYSTEMS, AND METHODS OF USING THE SAMEJanuary 2021February 2024Abandon3710NoNo
17156265DEVICES, SYSTEMS AND METHODS FOR DELIVERING A PROSTHETIC MITRAL VALVE AND ANCHORING DEVICEJanuary 2021February 2024Allow3710YesNo
17137829SURGICAL TOOL WITH TOOL-BASED TRANSLATION AND LOCK FOR THE SAMEDecember 2020April 2024Allow3910NoNo
17132522IMPLANT HAVING ADJUSTABLE FILAMENT COILSDecember 2020November 2024Allow4701YesNo
16972973PLAN-SPECIFIC INSTRUMENT TEMPLATE FOR PERCUTANEOUS INTERVENTIONAL PROCEDURESDecember 2020January 2025Allow5030YesNo
17111148DELIVERY SYSTEMS FOR PROSTHETIC HEART VALVEDecember 2020April 2023Allow2900YesNo
17055186INTRAOCULAR LENS INJECTOR WITH CONTAINERNovember 2020January 2025Allow5120YesNo
17093401METHODS AND SYSTEMS FOR TREATMENT OF ACUTE ISCHEMIC STROKENovember 2020February 2025Allow5230YesNo
17082904Implant Having Adjustable Filament CoilsOctober 2020September 2023Allow3500YesNo
17068593CATHETER DESIGN FOR USE IN TREATING PLEURAL DISEASESOctober 2020February 2024Allow4020YesNo
17065612EMBOLIC COIL DELIVERY SYSTEM WITH RETRACTABLE MECHANICAL RELEASE MECHANISMOctober 2020March 2023Allow3000YesNo
17065693MEMBRANE DELAMINATION DEVICEOctober 2020May 2024Allow4310NoNo
17062183OPEN CHANNEL IMPLANT TOOLS AND IMPLANT TECHNIQUES UTILIZING SUCH TOOLSOctober 2020February 2025Allow5341YesNo
17034511BLOOD PRESSURE MONITORING DEVICESeptember 2020September 2024Abandon4820NoNo
16948570ELECTROLYTIC AND MECHANICAL DETACHMENT FOR IMPLANT DELIVERY SYSTEMSSeptember 2020August 2023Allow3510NoNo
17022337SURGICAL INSTRUMENTS WITH ARTICULATING SHAFTSSeptember 2020March 2023Allow3000NoNo
17018804MITRAL HEART VALVE STORAGE AND HANDLING SYSTEMSeptember 2020February 2023Allow2900YesNo
17012678METHODS, COMPOSITIONS, AND DEVICES FOR THE OCCLUSION OF CAVITIES AND PASSAGEWAYSSeptember 2020January 2022Allow1720YesNo
16999449RETRACTABLE CAP ACTUATION FOR AN INTRAOCULAR LENS CARTRIDGEAugust 2020July 2023Allow3500YesNo
16999415PUSH MECHANISM FOR INTERFACING A DRIVE MECHANSIM HANDPIECE WITH AN INTROACULAR LENS CARTRIDGEAugust 2020October 2023Allow3710YesNo

Appeals Overview

This analysis examines appeal outcomes and the strategic value of filing appeals for examiner IGBOKO, CHIMA U.

Patent Trial and Appeal Board (PTAB) Decisions

Total PTAB Decisions
7
Examiner Affirmed
3
(42.9%)
Examiner Reversed
4
(57.1%)
Reversal Percentile
82.4%
Higher than average

What This Means

With a 57.1% reversal rate, the PTAB has reversed the examiner's rejections more often than affirming them. This reversal rate is in the top 25% across the USPTO, indicating that appeals are more successful here than in most other areas.

Strategic Value of Filing an Appeal

Total Appeal Filings
24
Allowed After Appeal Filing
8
(33.3%)
Not Allowed After Appeal Filing
16
(66.7%)
Filing Benefit Percentile
55.4%
Higher than average

Understanding Appeal Filing Strategy

Filing a Notice of Appeal can sometimes lead to allowance even before the appeal is fully briefed or decided by the PTAB. This occurs when the examiner or their supervisor reconsiders the rejection during the mandatory appeal conference (MPEP § 1207.01) after the appeal is filed.

In this dataset, 33.3% of applications that filed an appeal were subsequently allowed. This appeal filing benefit rate is above the USPTO average, suggesting that filing an appeal can be an effective strategy for prompting reconsideration.

Strategic Recommendations

Appeals to PTAB show good success rates. If you have a strong case on the merits, consider fully prosecuting the appeal to a Board decision.

Filing a Notice of Appeal is strategically valuable. The act of filing often prompts favorable reconsideration during the mandatory appeal conference.

Examiner IGBOKO, CHIMA U - Prosecution Strategy Guide

Executive Summary

Examiner IGBOKO, CHIMA U works in Art Unit 3771 and has examined 291 patent applications in our dataset. With an allowance rate of 83.5%, this examiner has an above-average tendency to allow applications. Applications typically reach final disposition in approximately 38 months.

Allowance Patterns

Examiner IGBOKO, CHIMA U's allowance rate of 83.5% places them in the 58% percentile among all USPTO examiners. This examiner has an above-average tendency to allow applications.

Office Action Patterns

On average, applications examined by IGBOKO, CHIMA U receive 2.41 office actions before reaching final disposition. This places the examiner in the 69% percentile for office actions issued. This examiner issues a slightly above-average number of office actions.

Prosecution Timeline

The median time to disposition (half-life) for applications examined by IGBOKO, CHIMA U is 38 months. This places the examiner in the 31% percentile for prosecution speed. Prosecution timelines are slightly slower than average with this examiner.

Interview Effectiveness

Conducting an examiner interview provides a +39.4% benefit to allowance rate for applications examined by IGBOKO, CHIMA U. This interview benefit is in the 87% percentile among all examiners. Recommendation: Interviews are highly effective with this examiner and should be strongly considered as a prosecution strategy. Per MPEP § 713.10, interviews are available at any time before the Notice of Allowance is mailed or jurisdiction transfers to the PTAB.

Request for Continued Examination (RCE) Effectiveness

When applicants file an RCE with this examiner, 23.4% of applications are subsequently allowed. This success rate is in the 32% percentile among all examiners. Strategic Insight: RCEs show below-average effectiveness with this examiner. Carefully evaluate whether an RCE or continuation is the better strategy.

After-Final Amendment Practice

This examiner enters after-final amendments leading to allowance in 19.3% of cases where such amendments are filed. This entry rate is in the 23% percentile among all examiners. Strategic Recommendation: This examiner rarely enters after-final amendments compared to other examiners. You should generally plan to file an RCE or appeal rather than relying on after-final amendment entry. Per MPEP § 714.12, primary examiners have discretion in entering after-final amendments, and this examiner exercises that discretion conservatively.

Pre-Appeal Conference Effectiveness

When applicants request a pre-appeal conference (PAC) with this examiner, 72.7% result in withdrawal of the rejection or reopening of prosecution. This success rate is in the 60% percentile among all examiners. Strategic Recommendation: Pre-appeal conferences show above-average effectiveness with this examiner. If you have strong arguments, a PAC request may result in favorable reconsideration.

Appeal Withdrawal and Reconsideration

This examiner withdraws rejections or reopens prosecution in 66.7% of appeals filed. This is in the 52% percentile among all examiners. Of these withdrawals, 42.9% occur early in the appeal process (after Notice of Appeal but before Appeal Brief). Strategic Insight: This examiner shows above-average willingness to reconsider rejections during appeals. The mandatory appeal conference (MPEP § 1207.01) provides an opportunity for reconsideration.

Petition Practice

When applicants file petitions regarding this examiner's actions, 25.5% are granted (fully or in part). This grant rate is in the 13% percentile among all examiners. Strategic Note: Petitions are rarely granted regarding this examiner's actions compared to other examiners. Ensure you have a strong procedural basis before filing a petition, as the Technology Center Director typically upholds this examiner's decisions.

Examiner Cooperation and Flexibility

Examiner's Amendments: This examiner makes examiner's amendments in 0.0% of allowed cases (in the 45% percentile). This examiner makes examiner's amendments less often than average. You may need to make most claim amendments yourself.

Quayle Actions: This examiner issues Ex Parte Quayle actions in 0.0% of allowed cases (in the 48% percentile). This examiner issues Quayle actions less often than average. Allowances may come directly without a separate action for formal matters.

Prosecution Strategy Recommendations

Based on the statistical analysis of this examiner's prosecution patterns, here are tailored strategic recommendations:

  • Prioritize examiner interviews: Interviews are highly effective with this examiner. Request an interview after the first office action to clarify issues and potentially expedite allowance.
  • Plan for RCE after final rejection: This examiner rarely enters after-final amendments. Budget for an RCE in your prosecution strategy if you receive a final rejection.

Relevant MPEP Sections for Prosecution Strategy

  • MPEP § 713.10: Examiner interviews - available before Notice of Allowance or transfer to PTAB
  • MPEP § 714.12: After-final amendments - may be entered "under justifiable circumstances"
  • MPEP § 1002.02(c): Petitionable matters to Technology Center Director
  • MPEP § 1004: Actions requiring primary examiner signature (allowances, final rejections, examiner's answers)
  • MPEP § 1207.01: Appeal conferences - mandatory for all appeals
  • MPEP § 1214.07: Reopening prosecution after appeal

Important Disclaimer

Not Legal Advice: The information provided in this report is for informational purposes only and does not constitute legal advice. You should consult with a qualified patent attorney or agent for advice specific to your situation.

No Guarantees: We do not provide any guarantees as to the accuracy, completeness, or timeliness of the statistics presented above. Patent prosecution statistics are derived from publicly available USPTO data and are subject to data quality limitations, processing errors, and changes in USPTO practices over time.

Limitation of Liability: Under no circumstances will IronCrow AI be liable for any outcome, decision, or action resulting from your reliance on the statistics, analysis, or recommendations presented in this report. Past prosecution patterns do not guarantee future results.

Use at Your Own Risk: While we strive to provide accurate and useful prosecution statistics, you should independently verify any information that is material to your prosecution strategy and use your professional judgment in all patent prosecution matters.